Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
- Resource Type
- Article
- Source
- Lancet Respiratory Medicine; Jan2023, Vol. 11 Issue 1, p87-96, 10p
- Subject
INTERSTITIAL lung diseases VITAL capacity (Respiration) COMPUTED tomography RHEUMATOID arthritis - Language
- ISSN
- 22132600